Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically identify ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an ...

Left to Right: Ethan Grimes, BS, and Paul Morgan, MD, conduct rational drug design at the newly launched AI Small Molecule Drug Discovery Center at the Icahn School of Medicine at Mount Sinai.

Mount Sinai's AI-powered ECG tool now predicts individual risk for hypertrophic cardiomyopathy (HCM), enabling faster ...

"Health care should be the same regardless of whether you're rich or poor," one of the study's co-authors told Newsweek.

Researchers from New York City-based Mount Sinai have developed an AI algorithm to help physicians identify patients with hypertrophic cardiomyopathy by assigning a numeric probability risk assessment ...

In the stillness of the night, when the body should lie calm in sleep, something else may be happening beneath the surface.

A team of US researchers, studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) said they have ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development ...

New York, NY, April 02, 2025 (GLOBE NEWSWIRE) -- The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial ...